Volume 9 Issue 3, Mar 2024

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 9 Issue 3, Mar 2024:
Editorial
Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA
Lang Zheng,Wenjing Wang &Qiu Sun  ORCID: orcid.org/0000-0001-5122-2226